Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Maha Hussain, MD, FACP, FASCO, on the potential impact of the PROSPER study

Dr. Hussain, Genevieve Teuton Professor of Medicine, Division of Hem/Onc, Deputy Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, outlines how the PROSPER study results might impact the treatment landscape in non-metastatic castrate resistant prostate cancer.

Published: 10 February 2018

Recent Videos

video

James Hamrick, MD, discusses the value of real world evidence data

Dr. Hamrick, Senior Medical Director, Flatiron Health, defines and elaborates on the importance of real world evidence

video

James Hamrick, MD, explains how real world evidence figures into clinical trial design

Dr. Hamrick, Senior Medical Director, Flatiron Health, shares how real world evidence figures into clinical trial design

video

James Hamrick, MD, on how practicing oncologists and the FDA could utilize real world evidence

Dr. Hamrick, Senior Medical Director, Flatiron Health, offers opinion on how practicing oncologists and the FDA could utilize real world ...

video

Ricky Newton discusses how PBMs are impacting in-office dispensing for oncology practices

Ricky Newton, Treasurer and Director of Financial Services and Operations, Head, Community Oncology Pharmacy Association (COPA), Community Oncology Alliance, explains ...

video

Ricky Newton on how COA has helped practices keep their in-office dispensing in network

Ricky Newton, Treasurer and Director of Financial Services and Operations, Head, Community Oncology Pharmacy Association (COPA), Community Oncology Alliance, considers ...

video

Ricky Newton shares what COA & COPA are doing to help practices treat at the point of care

Ricky Newton, Treasurer and Director of Financial Services and Operations, Head, Community Oncology Pharmacy Association (COPA), Community Oncology Alliance, elaborates ...

video

Ted Okon, MBA, regarding the key issues faced by community oncologists today

Ted Okon, MBA, Executive Director, Community Oncology Alliance, discusses the key issues faced by community oncologists today

video

Ted Okon, MBA, on what COA is doing to help community oncology practices

Ted Okon, MBA, Executive Director, Community Oncology Alliance, elaborates on what COA is doing to help community oncology practices

video

Ted Okon, MBA, considers what can be done to encourage PBM transparency

Ted Okon, MBA, Executive Director, Community Oncology Alliance, tells us what can be done to encourage transparency at PBMs

video

Ray Page, DO, PhD, on what oncology practices should be doing to advocate for their patients

Dr. Page, President & Director of Research, The Center for Cancer & Blood Disorders, offers opinion on what everyday oncology ...

Related Videos

video-image

James Hamrick, MD, discusses the value of real world evidence data

video-image

James Hamrick, MD, explains how real world evidence figures into clinical trial design

video-image

James Hamrick, MD, on how practicing oncologists and the FDA could utilize real world evidence

video-image

Ricky Newton discusses how PBMs are impacting in-office dispensing for oncology practices

video-image

Ricky Newton on how COA has helped practices keep their in-office dispensing in network

video-image

Ricky Newton shares what COA & COPA are doing to help practices treat at the point of care

video-image

Ted Okon, MBA, regarding the key issues faced by community oncologists today

video-image

Ted Okon, MBA, on what COA is doing to help community oncology practices

video-image

Ted Okon, MBA, considers what can be done to encourage PBM transparency

video-image

Nate Brown speculates on the future of MIPS and oncology practices

video-image

Robert Rifkin, MD, lists those biosimilars now approved or close to approval

video-image

Mark Fendrick, MD, provides examples of value-based insurance design in oncology care

video-image

Nate Brown offers opinion on whether practices in a MIPS track should consider moving to an APM

video-image

Robert Rifkin, MD, tells us about biosimilar pricing and reimbursement

video-image

Mark Fendrick, MD, considers the challenges associated with value-based insurance design

video-image

Ray Page, DO, PhD, explains cancer patient advocacy & how it enhances the delivery of cancer care

video-image

Ted Okon, MBA, on the impact of the reduction in reimbursement for hospitals participating in 340B

video-image

Mark Fendrick, MD, on designing incentives when dealing with expensive cancer therapies

video-image

Ray Page, DO, PhD, on what oncology practices should be doing to advocate for their patients

video-image

Ted Okon, MBA, speculates on the path forward regarding 340B policy